You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 1
  • CT-02 Features of patients screened for calibrate (rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis); hypogammaglobulinemia is frequent in patients with marked elevation of urinary protein

Citation Tools

Article menu

Download PDFPDF

Clinical Trials
CT-02 Features of patients screened for calibrate (rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis); hypogammaglobulinemia is frequent in patients with marked elevation of urinary protein
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Aranow C, Diamond B, Wofsy D, et al
CT-02 Features of patients screened for calibrate (rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis); hypogammaglobulinemia is frequent in patients with marked elevation of urinary protein
Lupus Science & Medicine 2016;3:doi: 10.1136/lupus-2016-000179.74